Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Medtronic
Novartis
Merck
Express Scripts
Daiichi Sankyo
Cerilliant
Dow
Fish and Richardson
Healthtrust

Generated: February 22, 2018

DrugPatentWatch Database Preview

Vale Company Profile

« Back to Dashboard

Summary for Vale
International Patents:227
US Patents:40
Tradenames:103
Ingredients:80
NDAs:128

Drugs and US Patents for Vale

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North FENOFIBRATE fenofibrate TABLET;ORAL 090715-002 Apr 5, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-005 Aug 24, 1999 AB3 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms Inc GRIS-PEG griseofulvin, ultramicrosize TABLET;ORAL 050475-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl HYTONE hydrocortisone LOTION;TOPICAL 080473-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl LIBRELEASE chlordiazepoxide CAPSULE, EXTENDED RELEASE;ORAL 017813-001 Sep 12, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Vale SERPATE reserpine TABLET;ORAL 009453-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North DERMATOP prednicarbate OINTMENT;TOPICAL 019568-001 Sep 23, 1991 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-006 Feb 6, 2003 AB RX Yes Yes 7,108,866 ➤ Try a Free Trial Y ➤ Try a Free Trial
Valeant Pharms Intl COLAZAL balsalazide disodium CAPSULE;ORAL 020610-001 Jul 18, 2000 AB RX Yes Yes 7,452,872*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Valeant Pharms North VASOTEC enalapril maleate TABLET;ORAL 018998-002 Dec 24, 1985 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Vale

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Luxembourg TARGRETIN bexarotene GEL;TOPICAL 021056-001 Jun 28, 2000 5,780,676 ➤ Try a Free Trial
Valeant Pharms Llc MACUGEN pegaptanib sodium INJECTABLE;INTRAVITREAL 021756-001 Dec 17, 2004 5,932,462 ➤ Try a Free Trial
Valeant Pharm Intl VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 6,150,337 ➤ Try a Free Trial
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 4,283,408*PED ➤ Try a Free Trial
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-003 Dec 30, 1988 4,166,182 ➤ Try a Free Trial
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 5,756,541 ➤ Try a Free Trial
Valeant Pharms Llc MACUGEN pegaptanib sodium INJECTABLE;INTRAVITREAL 021756-001 Dec 17, 2004 6,147,204 ➤ Try a Free Trial
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-002 Dec 30, 1988 4,797,405 ➤ Try a Free Trial
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-002 Nov 5, 1982 3,562,257 ➤ Try a Free Trial
Valeant Pharms Llc TIMOPTIC-XE timolol maleate SOLUTION, GEL FORMING/DROPS;OPHTHALMIC 020330-001 Nov 4, 1993 4,195,085 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for VALE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Inhalation Solution 6 gm/vial ➤ Subscribe 5/22/2014
➤ Subscribe Tablets 1.1 g ➤ Subscribe 11/5/2013
➤ Subscribe Extended-release Tablets 9 mg ➤ Subscribe 3/11/2013
➤ Subscribe Extended-release Capsules 0.375 g ➤ Subscribe 4/3/2012
➤ Subscribe Cream 0.5% ➤ Subscribe 7/29/2011
➤ Subscribe Capsules 75 mg ➤ Subscribe 6/6/2011
➤ Subscribe Gel 0.04% ➤ Subscribe 12/20/2010
➤ Subscribe Gel 0.1% ➤ Subscribe 7/8/2010
➤ Subscribe Extended-release Tablets 522 mg ➤ Subscribe 12/24/2009
➤ Subscribe Extended-release Tablets 174 mg ➤ Subscribe 9/28/2009
➤ Subscribe Extended-release Tablets 348 mg ➤ Subscribe 9/24/2009
➤ Subscribe Rectal Gel 5 mg/mL, 2mL pre-filled syringe ➤ Subscribe 12/23/2008
➤ Subscribe Rectal Gel 5 mg/mL, 4mL pre-filled syringe ➤ Subscribe 12/8/2008
➤ Subscribe Extended-release Tablets 300 mg ➤ Subscribe 9/25/2007
➤ Subscribe Extended-release Tablets 200 mg ➤ Subscribe 3/28/2007
➤ Subscribe Extended-release Tablets 100 mg ➤ Subscribe 1/8/2007
➤ Subscribe Extended-release Tablets 120 mg, 180 mg, 240 mg, 300 mg and 360 mg ➤ Subscribe 8/30/2005
➤ Subscribe Extended-release Tablets 420 mg ➤ Subscribe 4/25/2005
➤ Subscribe Extended-release Tablets 150 mg and 300 mg ➤ Subscribe 9/21/2004
➤ Subscribe Rectal Gel 2.5 mg/0.5 mL, 5 mg/mL, 10 mg/2 mL, 15 mg/3 mL and 20 mg/4 mL ➤ Subscribe 3/23/2004
Premature patent expirations for VALE

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
➤ Try a Free Trial ➤ Try a Free Trial

Non-Orange Book US Patents for Vale

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,029,823 Controlled release and taste masking oral pharmaceutical composition ➤ Try a Free Trial
6,143,327 Delayed release coated tablet of bupropion hydrochloride ➤ Try a Free Trial
7,553,992 Modified release formulations of a bupropion salt ➤ Try a Free Trial
7,884,136 Modified-release formulations of a bupropion salt ➤ Try a Free Trial
7,410,652 Controlled release and taste masking oral pharmaceutical composition ➤ Try a Free Trial
7,563,823 Modified release formulations of a bupropion salt ➤ Try a Free Trial
7,579,380 Modified release formulations of a bupropion salt ➤ Try a Free Trial
8,354,453 Bupropion hydrobromide and therapeutic applications ➤ Try a Free Trial
7,645,901 Modified release formulations of a bupropion salt ➤ Try a Free Trial
7,569,611 Modified release formulations of a bupropion salt ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Vale Drugs

Supplementary Protection Certificates for Vale Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB04/012 United Kingdom ➤ Try a Free Trial PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925
00097 Netherlands ➤ Try a Free Trial PRODUCT NAME: BOSENTAN, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN HYDRAAT OF IN DE VORM VAN EEN ESTER VAN DE HYDROXYLGROEP VAN DE 2-HYDROXYETHOXY REST MET EEN ZUUR MET DE FORMULE R5-OH, WAARIN R5 EEN C1-7-ALKANOYL, BENZOYL, OF HETEROCYCLYCARBONYL VOORSTELT; NATL. REGISTRATION NO/DATE: U/1/02/220/001 - 005 20020515; FIRST REGISTRATION: CH IKS 58841 01 - 02 20020228
2006004,C0957929 Lithuania ➤ Try a Free Trial PRODUCT NAME: PEGAPTANIBUM; REGISTRATION NO/DATE: EU/1/05/325/001 20060131
2015 00042 Denmark ➤ Try a Free Trial PRODUCT NAME: KOMBINATION AF SAFINAMID, HERUNDER SAFINAMID METHANSULFONAT, OG LEVODOPA/PDI; REG. NO/DATE: EU/1/14/984/001-010 20150226
172 Luxembourg ➤ Try a Free Trial PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
90049-3 Sweden ➤ Try a Free Trial PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
C/GB00/019 United Kingdom ➤ Try a Free Trial PRODUCT NAME: BUPROPION HYDROCHLORIDE; REGISTERED: NL RVG 24160 19991201; UK PL 10949/0340 20000607
2013025,C1304992 Lithuania ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
C/GB01/041 United Kingdom ➤ Try a Free Trial SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB01/041 GRANTED TO EISAI R + D MANAGEMENT., LTD. IN RESPECT OF THE PRODUCT BEXAROTENE (4-(1-(3, 5, 5, 8, 8-PENTAMETHYL-5, 6, 7, 8-TETRAHYDRO-2-NAPHTHALENYL)VINYL)BENZOIC ACID), WHICH WAS ADVERTISED AS COMING INTO FORCE IN JOURNAL NO 6469 DATED 15/05/2013 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, IT WILL EXPIRE ON 01/04/2016.
C/GB05/029 United Kingdom ➤ Try a Free Trial PRODUCT NAME: MESOTRIONE (2-(4-METHYLSULPHONYL-2-NITROBENZOYL)-1,3CYCLOHEXANEDIONE); REGISTERED: AU 2726 20001016; UK 0309 OF 2005 20050218
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
QuintilesIMS
Farmers Insurance
Fuji
Fish and Richardson
Harvard Business School
McKinsey
Argus Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot